Our findings suggest B7‐H3 plays an immunosuppressive role in OPSCC, which has been shown in a separate study of HNSCC, where the authors further demonstrated an association between B7‐H3 expression and poorer prognosis, highlighting the need for innovative immunotherapies.10 The gene discussed is CD276; the disease is head and neck squamous cell carcinoma.